Cargando…
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
A greater understanding of the biological mechanisms responsible for de novo and acquired endocrine resistance has led to the rational design of clinical trials exploring the benefit of combining hormonal therapies with novel biological agents in an effort to enhance the efficacy of ER+ breast cance...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242654/ https://www.ncbi.nlm.nih.gov/pubmed/17980056 http://dx.doi.org/10.1186/bcr1763 |